Papillomaviruses are small DNA viruses that are associated with benign and malignant epithelial lesions, including >95% of cervical cancers and Ϸ20% of head and neck cancers. Because papillomavirus replication and virion production are tied to epithelial cell differentiation, infectious papillomavirus virion production has been limited to cumbersome organotypic cultures and mouse xenografts. Consequent difficulties in obtaining useful amounts of wild-type or mutant human papillomavirus (HPV) virions have greatly limited studies on many aspects of papillomavirus biology. To overcome these limitations, we developed a system to encapsidate the full-length papillomaviral genome into infectious virions, independently of viral DNA replication and epithelial differentiation. This transient-transfection-based system produces >1,000 times more infectious virus per cell culture dish than the much more labor-intensive organotypic culture. Furthermore, we show that this method allows the facile generation of infectious particles containing wild-type, mutant, or chimeric papillomaviral genomes, overcoming barriers to studying many facets of replication, host interactions, and vaccine and drug development, which has been limited by the insufficient availability of infectious virions.infection ͉ virions ͉ virus packaging ͉ capsid ͉ DNA encapsidation P apillomaviruses are nonenveloped, double-stranded DNA viruses with Ϸ8-kb, circular genomes, 55-nm spherical capsids, wide distribution in higher vertebrates, and tight species specificity (1). Human papillomaviruses (HPVs), of which there are Ͼ100 genotypes, infect and replicate in cutaneous or mucosal epithelia, inducing benign lesions, including warts that are self-limiting and normally regress over time (2, 3). A subset of mucosotropic HPVs, the high-risk genotypes, such as HPV16, HPV18, and HPV31, are causally associated with anogenital cancers, including nearly all, if not all, cervical carcinomas, a leading cause of cancer death among women worldwide (1, 4, 5). Also, high-risk HPVs (in particular, HPV16) are associated with 20-30% of head and neck cancers (6, 7), the sixth most common cancer in the United States, of which the survival rate is Ͻ50% and has not improved for decades (8).The HPV life cycle is tightly linked to epithelial differentiation (9, 10). HPVs initially infect cells of the poorly differentiated, proliferative, basal compartment of stratified epithelia. Here, the viral genome sets up residence as a low-copy nuclear plasmid, a subset of viral genes (the early genes) are expressed at low levels, and no progeny virus is made. However, as infected basal cells divide and daughter cells migrate into the suprabasal compartment for terminal differentiation, the productive stage of the viral life cycle is initiated (10, 11). Here, the virus reprograms suprabasal cells to support high-copy-number amplification of the viral genome, the viral structural genes encoding the major L1 and minor L2 capsid proteins are expressed, and progeny virions are assembled and then ...